Markets · 1 sources covering this

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Molbio Diagnostics IPO entered its final bidding day with strong demand, with the Rs 939.70-crore issue subscribed 4.91 times. Its GMP has risen to 17.1%, signalling expectations of a strong listing. The IPO comprises a Rs 200-crore fresh issue and a Rs 739.70-crore OFS.

Share:WhatsApp X Reddit Facebook

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·2h ago
Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?
Molbio Diagnostics IPO entered its final bidding day with strong demand, with the Rs 939.70-crore issue subscribed 4.91 times. Its GMP has risen to 17.1%, signalling expectations of a strong listing. The IPO comprises a Rs 200-crore fresh issue and a Rs 739.70-crore OFS.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/77557bea94dd4553542bb532af36639c9d798ab0"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?"></iframe>

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

How 1 sources are covering this

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

More from Markets

CAS chaos: Retail traders call for boycott, declare 'No Trade Day'

Sebi sees no manipulation in new CAS despite participation concerns

NALCO, Hindalco gain up to 8% as global aluminium prices hit 7-week high amid Mideast tensions

India bonds hemmed in by oil worries ahead of inflation data

Reader

Trust & legal

Across the network